Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record.

REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: A Retrospective Study of 37 Patients with Pretransplant Anti-HBs and Anti-HBc

Dh??din, Nathalie, Douvin, Catherine, Kuentz, Mathieu, Saint Marc, Marie France, Reman, O., Rieux, Claire, Bernaudin, Fran??oise, Norol, Fran??oise, Cordonnier, Catherine, Bobin, Dominique, Metreau, Jean-Michel, Vernant, Jean-Paul·1998·Transplantation

Abstract

BACKGROUND: Reverse seroconversion to hepatitis B virus (HBV), i.e., HBV reactivation in patients with pretransplant antibodies to hepatitis B surface antigen (anti-HBs) and to hepatitis B core antigen (anti-HBc), is rarely re-ported after allogeneic bone marrow transplantation. METHODS: To determine this risk, we studied clinical outcome and serological changes in 37 patients with pretransplant anti-HBs and anti-HBc. RESULTS: In 33 cases, no change in HBV markers was observed in the posttransplant period. In four cases, anti-HBs and anti-HBc were lost, and hepatitis B surface antigen, hepatitis B e antigen, and HBV DNA emerged together with acute hepatitis, after cessation of immunosuppression. The actuarial risk of reactivation in the 37 patients was 20.5% (median follow-up 20 months). No reactivation occurred in patients with anti-HBs-positive donors. CONCLUSION: Although few cases of postallogeneic bone marrow transplantation reverse seroconversion to HBV have been reported, this study demonstrates that the actuarial risk is relatively high and suggests that donor vaccination might be proposed prophylactically or that HBs-specific immunoglobulin infusions might be warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00007890-199809150-00012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 174

Metadata

Authors
Dh??din, N., Douvin, C., Kuentz, M., Saint Marc, M. F., Reman, O., Rieux, C., Bernaudin, F., Norol, F., Cordonnier, C., Bobin, D., Metreau, J.-M., & Vernant, J.-P.
Venue
Transplantation
Published
1998-09
Volume
66
Issue
5
Pages
616-619
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2061551385
Cited by
174
References
0
FWCI
2.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: A Retrospective Study of 37 Patients with Pretransplant Anti-HBs and Anti-HBc. https://app.cochat.ai/papers/10.1097/00007890-199809150-00012
The paper
Dh??din, N., Douvin, C., Kuentz, M., Saint Marc, M. F., Reman, O., Rieux, C., Bernaudin, F., Norol, F., Cordonnier, C., Bobin, D., Metreau, J.-M., & Vernant, J.-P. (1998). REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION: A Retrospective Study of 37 Patients with Pretransplant Anti-HBs and Anti-HBc. Transplantation. https://doi.org/10.1097/00007890-199809150-00012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.